|
Press Releases |
|
 |
|
Tuesday, March 26, 2024 |
|
博维公布2023年全年业绩 |
提供全面、优质及端对端企业IT解决方案的大湾区市场领先企业博维智慧科技有限公司(“博维”或连同附属公司统称为“集团”; 股份代号:1204.HK),今天公布其截至2023年12月31日止年度的全年业绩(“2023年”或“年内”)。 more info >> |
|
博維公佈2023年全年業績 |
提供全面、優質及端對端企業IT解決方案的大灣區市場領先企業博維智慧科技有限公司(「博維」或連同附屬公司統稱為「集團」; 股份代號:1204.HK),今天公佈其截至2023年12月31日止年度的全年業績(「2023年」或「年內」)。 more info >> |
|
BoardWare Announces 2023 Annual Results |
BoardWare Intelligence Technology Limited ("BoardWare" or together with its subsidiaries, the "Group"; stock code: 1204.HK), a leading company in the Greater Bay Area ("GBA") that offers comprehensive more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
U.S. Polo Assn. Returns as Official Apparel and Jersey Partner for Chestertons Polo in the Park in Downtown London
Jun 10, 2025 23:27 HKT/SGT
|
|
|
New HKTDC Chairman Frederick Ma keen to promote Hong Kong as best partner for global enterprises
Jun 10, 2025 22:28 HKT/SGT
|
|
|
爆款IPO前瞻:「香水第一股」穎通控股強勢登場!港股IPO再現黃金賽道 龍頭勢掀「嗅覺經濟」新浪潮
Jun 10, 2025 19:10 HKT/SGT
|
|
|
爆款IPO前瞻:“香水第一股”颖通控股强势登场!港股IPO再现黄金赛道 龙头势掀“嗅觉经济”新浪潮
Jun 10, 2025 19:10 HKT/SGT
|
|
|
Supercomputer Fugaku retains first place worldwide in Graph500 rankings
Jun 10, 2025 19:47 JST
|
|
|
ダイムラートラック、三菱ふそう、日野、トヨタ、三菱ふそうと日野の統合に関する最終合意を締結
Jun 10, 2025 16:30: JST
|
|
|
聯想控股副總裁于浩:在技術變革中錨定「長期主義」
Jun 10, 2025 15:37 HKT/SGT
|
|
|
联想控股副总裁于浩:在技术变革中锚定"长期主义"
Jun 10, 2025 15:28 HKT/SGT
|
|
|
Ai sẽ là người đầu tiên ghi danh vào lịch sử với tư cách là Nhà Vô Địch Thế Giới đầu tiên?!
Jun 10, 2025 14:00 HKT/SGT
|
|
|
Siapakah yang akan mengukir nama dalam sejarah sebagai "Juara Dunia Pertama"!
Jun 10, 2025 14:00 HKT/SGT
|
|
|
Siapakah yang akan mengukir namanya dalam sejarah sebagai “Juara Dunia Pertama”!
Jun 10, 2025 14:00 HKT/SGT
|
|
|
誰將成為名留青史的「初代世界冠軍」!
Jun 10, 2025 14:00 HKT/SGT
|
|
|
UK MOD Signs Protector Support Contract with GA-ASI
Jun 10, 2025 06:00 HKT/SGT
|
|
|
SRKay Consulting Group Releases Research Report: 'From Legal Frameworks to Successful Operations'--A Strategic Playbook for India Market Entry
Jun 9, 2025 17:00 HKT/SGT
|
|
|
Everest Medicines Presents Positive Results from Phase 1b/2a Clinical Trial of EVER001 for Primary Membranous Nephropathy at ERA 2025
Jun 9, 2025 12:52 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|